久久久久免费_精品国产乱码久久久久久久软件_欧美一区亚洲一区_国产一区二区三区高清在线观看_欧美日在线观看_成人网av

美國IRIS International  
Iris集團于1979年成立，總部位于洛杉磯北部，并在納斯達克上市。Iris集團旗下包括：Iris診斷、Iris德國公司、Iris 分子診斷、Iris樣品處理。其中Iris診斷一直致力于開發和研究體外診斷產品，為客戶提供可靠的成本效益解決方案。經驗豐富的研究人員不斷地開發創新體外診斷技術以擴大最初的產品平臺，因為不懈的努力，IRIS診斷的數字影像處理技術水平在業界領先，且是尿液分析系統的全球領導者。

    

 


Since 1979, IRIS International, Inc. (NASDAQ: IRIS), has been dedicated to the development and commercialization of innovative medical diagnostics and sample processing products that provide reliable and cost effective solutions for our customers and improved disease management for the patients we serve. IRIS invented and introduced the first automated urinalysis system and in the following years added numerous innovations and improvements, making us the world leader in this technology. Our automated urinalysis systems and sample processing products are today used in hospitals, clinical reference laboratories, veterinary laboratories and research facilities around the world.

Our management and scientists, engineers and senior technical staff with many years of healthcare experience have broadened our initial product platform and have successfully focused on the development and commercialization of innovative in-vitro diagnostics products and solutions, which expand our core imaging and morphology expertise into related markets of oncology, hematology, and microbiology.
Our manufacturing and research activities are conducted through three operating units: Iris Diagnostics Division, Iris Sample Processing Division (formerly StatSpin, Inc.) and Iris Molecular Diagnostics research and development subsidiary. The core competencies in these operating groups include flow imaging technology, morphological pattern recognition, chemistry, ultra-sensitive detection of proteins and rapid and reliable processing of blood and other body fluids. This broad expertise is now being utilized by Iris in the development of a series of "disruptive" technologies, which we believe will introduce a number of new products that will change and sharply advance the fields of urinalysis, hematology, cancer diagnostics and sample processing for human and veterinary applications.

Our 300+ employees take pride in our customers’ contributions to medical science and to improving the lives of patients and are especially aware of the role we play in providing our customers products and services which enable them to carry out their mission to provide better healthcare.